[{"Assets_0_Q2_USD":11428700000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":158300000.0,"NetIncomeLoss_2_Q2_USD":72900000.0,"NetIncomeLoss_1_Q2_USD":9000000.0,"StockholdersEquity_0_Q2_USD":5726200000.0,"EarningsPerShareBasic_1_Q2_USD":0.07,"EarningsPerShareBasic_2_Q2_USD":0.54,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":136000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":136000000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190808"}]